Former GlaxoSmithKline, Campbell's Executive named MusclePharm CMO

Former GlaxoSmithKline, Campbell's Executive named MusclePharm CMO

MusclePharm Corporation, a nutritional supplement company focused on active lifestyles, announced that Sydney Rollock has joined the company as Chief Marketing Officer. In this role, Rollock will oversee global brand management, global marketing and sales, as well as help lead MusclePharm's corporate strategy to ultimately grow product lines and revenue streams.

"We are thrilled to add an executive of Sydney's caliber to our growing company," said Brad Pyatt, founder and CEO, MusclePharm. "Sydney brings tremendous knowledge and experience from within the Pharma, Pharma OTC, Health & Wellness and Nutritional Supplements categories, giving him the insight to develop targeted marketing initiatives that will resonate with our customers."

With over 20 years of experience in marketing and general management, Rollock has been instrumental in growing brand portfolios in both global Fortune 500 companies (GlaxoSmithKline, Coca-Cola, Campbell's, and General Mills) and entrepreneurial companies. Rollock joins MusclePharm from XXIC, where he was Founder and President. XXIC partnered with investors to identify and evaluate non-core consumer Fortune 500 brand businesses in the OTC Health & Wellness sector, with the intent of bringing buyers and sellers together to form a stand-alone specialty premium Consumer OTC Company.

"I'm looking forward to joining forces with MusclePharm's executive team," said Rollock. "I  believe that there is major growth potential with the company's cutting-edge product lines and present and future partnerships."

Before founding XXIC, Rollock held leadership positions within marketing and general management at Brightside Academy Inc. and at GlaxoSmith Kline Consumer Healthcare North America as Vice President and General Manager of two of their major business units. Rollock received his M.B.A. from the University of Michigan, Ross School of Business.    

In other company matters: Executive Vice President John Bluher has resigned to pursue a new opportunity. Bluher will stay on the Board of Directors until December 31, 2013 as this transition happens.

Bluher stated" "Brad and I executed a plan to recapitalize the company and reposition MusclePharm to grow as it is. I came here to help with the reorganization of the company and to help seat and run the Board as Co-Chairman. My work is done at MusclePharm, and I am working on a new opportunity to run my own company. Brad and I have an amazing friendship and mutual respect for each other and I wish MusclePharm and Brad all the best in future success."

 Source: PR Newswire